UNSPSC 85815216: Introduction of other antineoplastic into respiratory tract, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into respiratory tract, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F805

UNSPSC 85815216, Introduction of other antineoplastic into respiratory tract via natural or artificial opening endoscopic, is a Commodity code that shows no recent state and local procurement activity aligned with its medical procedure classification. The source data presents forty-two recent state and local contract opportunities tagged under this code, yet none describe the introduction of antineoplastic agents via endoscopic respiratory tract procedures; instead, they encompass virtual urgent care, medical services, PACE operations, occupational health services, cancer registry support, retinal screening devices, EMS staffing, employee health clinics, wellness programs, telehealth platforms, and substance-use disorder treatment—none of which map to the code's nominal clinical scope.

The mismatch reflects a broader taxonomy challenge: state and local procurement offices sometimes apply codes that do not reflect actual work scope. This code warrants skipping in pursuit of opportunities unless your firm specifically delivers antineoplastic agent therapy via endoscopic respiratory pathways to state or local health systems or corrections departments. The recent activity data provides no evidence of demand for this specialized service line at the state and local level.